⌘K

Login Start Free

Home/Filings/4/0001209191-22-020962

4//SEC Filing

Sauer Paul 4

Accession 0001209191-22-020962

CIK 0001649094other

View on SEC.gov Company Profile

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 6:05 PM ET

Size

4.8 KB

Accession

0001209191-22-020962

Insider Transaction Report

Form 4

Period: 2022-03-22

Vaxcyte, Inc.PCVX

SVP Process Dev, Manufacturing

Transactions

Sale
Common Stock
2022-03-22$25.00/sh−3,000$75,000→ 28,125 total

Footnotes (1)

[F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Vaxcyte, Inc.

CIK 0001649094

Entity typeother

Related Parties

1

filerCIK 0001813796

Filing Metadata

Form type: 4
Filed: Mar 23, 8:00 PM ET
Accepted: Mar 24, 6:05 PM ET
Size: 4.8 KB

View on SEC.gov